Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A drug, used in the treatment of certain types of cancer, that acts in a similar way to erlotinib by selectively targeting the mutant proteins in malignant cells.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

Unknown + -tinib

Support

Help support Wordnik (and make this page ad-free) by adopting the word gefitinib.

Examples

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS Editors 2010

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS Editors 2010

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS 2010

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS 2010

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS Editors 2010

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS Editors 2010

  • Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce t ...

    THE MEDICAL NEWS 2009

  • Specifically, we show that responsiveness to alternative HER-targeted inhibitors, such as gefitinib and cetuximab, is dramatically potentiated by long-term trastuzumab treatment of ovarian cancer cells.

    BioMed Central - Latest articles Jason Wilken 2010

  • Emerging evidence indicates that cMET inhibition may be useful in the treatment of certain cancers, including gastric and kidney cancer [2], and may help to overcome resistance to some targeted therapies, such as gefitinib in non-small cell lung cancer [3].

    WebWire | Recent Headlines 2009

  • Emerging evidence indicates that cMET inhibition may be useful in the treatment of certain cancers, including gastric and kidney cancer [2], and may help to overcome resistance to some targeted therapies, such as gefitinib in non-small cell lung cancer [3].

    WebWire | Recent Headlines 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.